Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Solarea Bio is raising $14,826,612.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Gerardo Toledo played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Solarea Bio

Solarea Bio is a biotech company in Cambridge MA building solutions for health disorders using bacteria and fungi native to healthy foods to create powerful synergistic, anti-inflammatory microbial assemblages. Launched at the Illumina Accelerator in 2017, Solarea has built a powerful platform using microbial discovery and genomics to rapidly deliver novel products to prevent the onset or progression of health problems associated to chronic inflammation.

To learn more about Solarea Bio, visit http://www.solareabio.com/

Contact:
Gerardo Toledo, Chief Executive Officer
617-497-4611
https://www.linkedin.com/in/gerardo-v-toledo-2007411/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved